Share-based Payment Arrangement, Expense of ProMIS Neurosciences Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ProMIS Neurosciences Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • ProMIS Neurosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $197,147, a 63% increase year-over-year.
  • ProMIS Neurosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,277,646, a 1644% increase year-over-year.
  • ProMIS Neurosciences Inc. annual Share-based Payment Arrangement, Expense for 2024 was $825,808, a 204% increase from 2023.
  • ProMIS Neurosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $271,542, a 44% decline from 2022.
  • ProMIS Neurosciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $487,630, a 5.4% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ProMIS Neurosciences Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,277,646 $197,147 +$76,111 +63% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,201,535 $212,015 +$194,016 +1078% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $1,007,519 $245,295 +$181,711 +286% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $825,808 $623,189 +$752,539 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $73,269 $121,036 -$13,155 -9.8% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $86,424 $17,999 -$116,192 -87% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $202,616 $63,584 -$68,926 -52% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $271,542 $129,350 -$266,588 -194% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $538,130 $134,191 +$25,607 +24% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $512,523 $134,191 +$17,248 +15% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $495,275 $132,510 +$7,645 +6.1% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $487,630 $137,238 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $108,584 -$81,045 -43% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $116,943 -$9,321 -7.4% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $124,865 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $189,629 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $126,264 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2

ProMIS Neurosciences Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $825,808 +$554,266 +204% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $271,542 -$216,088 -44% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $487,630 -$27,999 -5.4% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $515,629 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.